Dan Liu, Wei Mao, Bin Hu, Xingxing Li, Quanfeng Zhao, Lin Zhang, & Jing Hu. (2024). A real-world pharmacovigilance study of polatuzumab vedotin based on the FDA adverse event reporting system (FAERS). Frontiers Media S.A..
Chicago Style (17th ed.) CitationDan Liu, Wei Mao, Bin Hu, Xingxing Li, Quanfeng Zhao, Lin Zhang, and Jing Hu. A Real-world Pharmacovigilance Study of Polatuzumab Vedotin Based on the FDA Adverse Event Reporting System (FAERS). Frontiers Media S.A., 2024.
MLA (9th ed.) CitationDan Liu, et al. A Real-world Pharmacovigilance Study of Polatuzumab Vedotin Based on the FDA Adverse Event Reporting System (FAERS). Frontiers Media S.A., 2024.
Warning: These citations may not always be 100% accurate.